Sheila Moura Pone

Prof. Dr. Sheila Moura Pone

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KNKarin Nielsen-Saines
Karin Nielsen-Saines
PBPatrícia Brasil
Patrícia Brasil
TKTara Kerin
Tara Kerin
Zilton VasconcelosZilton Vasconcelos
Zilton Vasconcelos
CGClaudia Raja Gabaglia
Claudia Raja Gabaglia
MMMaria E. Moreira
Maria E. Moreira

1 September 2017 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
AZAndrea A. Zin
Andrea A. Zin
ITIrena Tsui
Irena Tsui
JRJulia Rossetto
Julia Rossetto
Zilton VasconcelosZilton Vasconcelos
Zilton Vasconcelos
KAKristina Adachi
Kristina Adachi
MMMaria Elisabeth Lopes Moreira
Maria Elisabeth Lopes Moreira
Zika virus is a flavivirus that can be spread by mosquito vectors, sexual contact, infected blood products, and perinatal transmission.1 In May 2015, a large outbreak of Zika virus infection was detected in northeastern Brazil that yielded an exceedingly high number of microcephaly cases.2 Thereafter, the epidemic rapidly spread to other countries in the Americas and Asia. In the United States, the first case of non–travel-related, locally transmitted Zika virus infection was reported in Florida in July 2016.3

13 December 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MMM. Elisabeth Lopes Moreira
M. Elisabeth Lopes Moreira
KNKarin Nielsen-Saines
Karin Nielsen-Saines
PBPatrícia Brasil
Patrícia Brasil
TKTara Kerin
Tara Kerin
LDLuana Damasceno
Luana Damasceno
JCJames D. Cherry
James D. Cherry
During the Zika virus (ZIKV) epidemic in Rio de Janeiro from September 2015 through June 2016, a prospective cohort study involving symptomatic pregnant women who had ZIKV infection confirmed by reverse-transcriptase–polymerase-chain-reaction assay was established.1 The study was approved by the institutional review boards at Fundação Oswaldo Cruz in Rio de Janeiro and the University of California, Los Angeles, and all the women provided written informed consent for themselves and their children.

3 July 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
KPKara-Lee Pool
Kara-Lee Pool
KAKristina Adachi
Kristina Adachi
SKStellios Karnezis
Stellios Karnezis
NSNoriko Salamon
Noriko Salamon
TRTahmineh Romero
Tahmineh Romero
MPMarcos Vinicius da Silva Pone
Marcos Vinicius da Silva Pone
Zika virus (ZIKV) infection during pregnancy can cause a spectrum of central nervous system (CNS) abnormalities.1-3 Infants severely affected by ZIKV classically present with microcephaly, other structural brain abnormalities, ocular abnormalities, congenital contractures, and profound neurologic impairment.2 Clinical findings of ZIKV-exposed neonates with severe congenital ZIKV have been well described, including among several neuroimaging reports,2-6 but the utility of neuroimaging for less severely affected infants is unclear. This study describes neuroimaging (computed tomography [CT] and/or magnetic resonance imaging [MRI]) findings and clinical outcomes in ZIKV-exposed infants with a range of clinical findings at birth. Our primary aims were as follows: (1) to review neuroimaging of infants with antenatal ZIKV exposure and to determine whether neuroimaging (CT and/or MRI) findings were associated with infant clinical outcomes and (2) to determine whether the gestational age at in utero ZIKV infection was associated with neuroimaging findings.

26 March 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
DODulce H G Orofino
Dulce H G Orofino
SPSonia Regina Lambert Passos CAPES 88881 130793 Passos
Sonia Regina Lambert Passos CAPES 88881 130793 Passos
RORaquel de Vasconcellos Carvalhaes de Oliveira
Raquel de Vasconcellos Carvalhaes de Oliveira
CFCarla Verona B Farias
Carla Verona B Farias
MLMaria de Fátima FATIMA Monteiro Pereira Leite
Maria de Fátima FATIMA Monteiro Pereira Leite
KNKarin Nielsen-Saines
Karin Nielsen-Saines
Antenatal exposure to Zika virus (ZIKV) is related to severe neurological manifestations. A previous study in Brazil reported an increased incidence of non-severe congenital heart defects in infants with diagnosis of congenital Zika syndrome but without laboratory confirmation of ZIKV infection in the mother or infant. The objective of this study is to report echocardiographic (ECHO) findings in infants with laboratory confirmed antenatal exposure to ZIKV. Cross sectional study of cardiologic assessments of infants born between November 2015 and January 2017 with confirmed vertical exposure to ZIKV in Rio de Janeiro, Brazil. The study enrolled 120 children with a median age of 97 days (1 to 376 days). In utero exposure to ZIKV was confirmed in 97 children (80,8%) through positive maternal polymerase chain reaction (PCR) results during pregnancy or a positive PCR result at birth; 23 additional children (19.2%) had maternal positive PCR results during pregnancy and postnatally. Forty- eight infants (40%) had cardiac defects noted on ECHO. Thirteen infants (10.8%) had major cardiac defects (atrial septal defect, ventricular septal defect, patent ductus arteriosus). None of the defects were severe. The frequency of major defects was higher in infants whose mothers had a rash in the 2nd trimester of pregnancy, or who had altered Central Nervous System (CNS) imaging postnatally or were preterm. Infants with in utero ZIKV exposure have a higher prevalence of major cardiac defects, however none were severe enough to require immediate intervention. For this reason, guidelines for performance of postnatal ECHO in this population should follow general newborn screening guidelines, which significantly reduces the burden of performing emergent fetal or neonatal ECHOs in a setting where resources are not available, such as most Brazilian municipalities. We performed cardiologic assessment of 120 infants born between November 2015 and January 2017 with confirmed vertical exposure to Zika virus (ZIKV). The diagnosis of ZIKV exposure was confirmed by PCR in maternal blood specimens and/or amniotic fluid during pregnancy and/or infant specimens including PCR of the cerebrospinal fluid (CSF) and/or urine following birth. Our study found a 10.8% incidence of structural heart defects in infants with a history of intrauterine exposure to ZIKV, a rate considerably higher than that observed in the general population. However, no patients were found to have severe structural heart defects. The presence of major defects was increased in infants whose mothers had a history of rash in the 2nd trimester, infants with altered CNS imaging and/or preterm infants. As severe heart defects requiring immediate intervention were not identified, guidelines for performance of postnatal ECHO in this population should follow the same criteria as the ones applicable to newborns in general, particularly since resources for performance of fetal and neonatal echocardiograms are not routinely available in most Brazilian municipalities

14 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
PBPatrícia Brasil
Patrícia Brasil
Zilton VasconcelosZilton Vasconcelos
Zilton Vasconcelos
TKTara Kerin
Tara Kerin
CGClaudia Raja Gabaglia
Claudia Raja Gabaglia
IRIeda P. Ribeiro
Ieda P. Ribeiro
KNKarin Nielsen-Saines
Karin Nielsen-Saines
We report Zika virus (ZIKV) vertical transmission in 130 infants born to PCR+ mothers at the time of the Rio de Janeiro epidemic of 2015–2016. Serum and urine collected from birth through the first year of life were tested by quantitative reverse transcriptase polymerase chain reaction (PCR) and/or IgM Zika MAC-ELISA. Four hundred and seven specimens are evaluated; 161 sera tested by PCR and IgM assays, 85 urines by PCR. Sixty-five percent of children (N = 84) are positive in at least one assay. Of 94 children tested within 3 months of age, 70% are positive. Positivity declines to 33% after 3 months. Five children are PCR+ beyond 200 days of life. Concordance between IgM and PCR results is 52%, sensitivity 65%, specificity 40% (positive PCR results as gold standard). IgM and serum PCR are 61% concordant; serum and urine PCR 55%. Most children (65%) are clinically normal. Equal numbers of children with abnormal findings (29 of 45, 64%) and normal findings (55 of 85, 65%) have positive results, p = 0.98. Earlier maternal trimester of infection is associated with positive results (p = 0.04) but not clinical disease (p = 0.98). ZIKV vertical transmission is frequent but laboratory confirmed infection is not necessarily associated with infant abnormalities.